You have 9 free searches left this month | for more free features.

Levonorgestrel

Showing 51 - 75 of 481

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Control of Bleeding on Nexplanon in Latinx Patients

Not yet recruiting
  • Contraception
  • 150 mcg levonorgestrel/30 mcg ethinyl estradiol
  • (no location specified)
Nov 1, 2021

Bioequivalence Trial in Santiago (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Levonorgestrel 15.0 mg and

Completed
  • Bioequivalence
  • Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
  • Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Reference Product
  • Santiago, Chile
    Innolab
Feb 8, 2021

Bioequivalence Trial in Santiago (Levonorgestrel 0.1 mg and Ethinyl estradiol 0.02 mg Test Product, Levonorgestrel 0.1 mg and

Completed
  • Bioequivalence
  • Levonorgestrel 0.1 mg and Ethinyl estradiol 0.02 mg Test Product
  • Levonorgestrel 0.1 mg and Ethinyl estradiol 0.02 mg Reference Product
  • Santiago, Chile
    Innolab
Feb 8, 2021

Healthy Adults Trial in Anaheim (PF-06882961, Atorvastatin, Midazolam)

Completed
  • Healthy Adults
  • Anaheim, California
    Anaheim Clinical Trials, LLC
Jul 21, 2022

HIV, Contraception Trial in Kampala (Levonorgestrel, Efavirenz)

Completed
  • HIV
  • Contraception
  • Kampala, Uganda
    Infectious Diseases Institute
Jan 20, 2021

Pharmacokinetics, Pharmacodynamics Trial in Moenchengladbach (laquinimod, Placebo)

Completed
  • Pharmacokinetics
  • Pharmacodynamics
  • Moenchengladbach, Germany
    Teva Investigational Site 32415
Nov 5, 2021

Tubal Ligation Trial in Assiut (Levonorgestrel-releasing intrauterine system)

Recruiting
  • Tubal Ligation
  • Levonorgestrel-releasing intrauterine system
  • Assiut, Egypt
    Women Health Hospital - Assiut university
Dec 5, 2020

Pregnancy Rates, PK Interactions Among HIV+ Women on EFV

Completed
  • HIV Infections
    • Lilongwe, Malawi
      UNC Project
    Feb 23, 2022

    Adenomyosis, Chronic Pelvic Pain Trial (LNG-IUS 13,5 mg Levonorgestrel, Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg)

    Unknown status
    • Adenomyosis
    • Chronic Pelvic Pain
    • LNG-IUS 13,5 mg Levonorgestrel
    • Levonorgestrel 0,10 mg+ ethinylestradiol 0,02 mg
    • (no location specified)
    Feb 3, 2021

    Mucosal Inflammation, Contraceptive; Complications, Intrauterine Trial in Norfolk, Thika (Copper IUD, Etonogestrel implant,

    Recruiting
    • Mucosal Inflammation
    • Contraceptive; Complications, Intrauterine
    • Copper IUD
    • +3 more
    • Norfolk, Virginia
    • +1 more
    Apr 7, 2022

    HIV-1-infection Trial in Reutov (Elpida®, Rifampin, Rifabutin)

    Completed
    • HIV-1-infection
    • Reutov, Moscow Region, Russian Federation
      Central Clinical City Hospital
    Jan 10, 2022

    Endometrial Hyperplasia Without Atypia Trial in Kocaeli (Vaginal Micronized Progesterone, Levonorgestrel-Intrauterine System)

    Completed
    • Endometrial Hyperplasia Without Atypia
    • Vaginal Micronized Progesterone
    • Levonorgestrel-Intrauterine System
    • Kocaeli, Turkey
      Kocaeli University
    Dec 1, 2020

    Immune Cells in Women Using Contraception (CHIC II)

    Completed
    • HIV
    • +2 more
    • levonorgestrel exposure
    • +4 more
    • Pittsburgh, Pennsylvania
      Center for Family Planning Research
    Dec 22, 2021

    Relapsing Multiple Sclerosis (RMS) Trial in Germany, Poland (Cladribine, Placebo, Microgynon®)

    Active, not recruiting
    • Relapsing Multiple Sclerosis (RMS)
    • Bochum, Germany
    • +6 more
    Feb 8, 2022

    Sites to Test Whether SAMANTA Questionnaire That is Used to

    Completed
    • Menorrhagia
    • Chronic hormonal treatment
    • Multiple Locations, Spain
      Many locations
    Mar 29, 2022

    Contraception Trial in Ireland, United Kingdom, United States (CDB-2914, Levonorgestrel)

    Completed
    • Contraception
    • Los Angeles, California
    • +32 more
    Apr 11, 2022

    HIV, Contraception, Drug-drug Interaction Trial in Eldoret (Cabotegravir/ Rilpivirine, Etonogestrel (ETG) implant, Intramuscular

    Recruiting
    • HIV Infections
    • +2 more
    • Cabotegravir/ Rilpivirine
    • +4 more
    • Eldoret, Kenya
      Academic Model Providing Access to Healthcare (AMPATH) Moi Teach
    Mar 30, 2022

    Contraception Trial in United States (LevoCept)

    Completed
    • Contraception
    • Berkeley, California
    • +15 more
    Apr 4, 2022

    Diabetes, Type 2 Trial in Berlin (Semaglutide 1.34 mg/mL, Semaglutide 3.0 mg/mL, NNC0480-0389 10 mg/mL)

    Recruiting
    • Diabetes Mellitus, Type 2
    • Semaglutide 1.34 mg/mL
    • +4 more
    • Berlin, Germany
      Novo Nordisk Investigational Site
    Jan 3, 2022

    Incomplete Abortion, Intrauterine Contraception, Misoprostol Trial in Wakiso (Use of either copper T380A or Levonorgestrel LNG

    Not yet recruiting
    • Incomplete Abortion
    • +2 more
    • Use of either copper T380A or Levonorgestrel LNG 52 IUS after medical management of first trimester incomplete abortion
    • Wakiso, Central, Uganda
      Herbert Kayiga
    Apr 20, 2022

    Hormonal Contraceptive Methods on Immunologic Changes in Female

    Recruiting
    • Hormonal Contraception
    • Depot medroxyprogesterone acetate (DMPA)
    • +2 more
    • Atlanta, Georgia
    • +2 more
    Aug 15, 2022

    Overweight, Obesity Trial in Montreal (NNC0174-0833, Oral contraceptive (OC) tablets, Acetaminophen)

    Completed
    • Overweight
    • Obesity
    • Montreal, Quebec, Canada
      Novo Nordisk Investigational Site
    Jan 6, 2022

    Endometrial Cancer, Atypical Endometrial Hyperplasia Trial in Chengdu (Progesterone, Mirena®, GnRH agonist)

    Recruiting
    • Endometrial Cancer
    • Atypical Endometrial Hyperplasia
    • Chengdu, Sichuan, China
      West China Second University Hospital
    Sep 3, 2021

    Healthy Subjects Trial in Rennes (Combined oral contraceptives (COC), Moxifloxacin 400mg, Cenerimod 0.5 mg)

    Completed
    • Healthy Subjects
    • Combined oral contraceptives (COC)
    • +5 more
    • Rennes, France
      Site 1
    Nov 15, 2022

    Contraception Trial (NOMAC-E2, LNG-EE)

    Completed
    • Contraception
    • (no location specified)
    Feb 7, 2022